111111 ⎘
ssRNA viruses negative-sense; Details; Rhabdoviridae; Vesiculovirus, e.g. vesicular stomatitis Indiana virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT
#2THERAPEUTIC RECOMBINANT VIRUSES
#3SELF-REPLICATING RNA VACCINES AND METHODS OF USE
#4Dual-Action Recombinant Vesicular Stomatitis Virus (RVSV)-Based Vaccine (DAV) Against COVID-19 and Influenza Viruses
#5USE OF ENGINEERED JURONA VIRUS (JURV) AS AN ONCOLYTIC VIRUS PLATFORM FOR HUMAN CANCERS
#6RECOMBINANT VIRAL VECTOR AND USES THEREOF
#7Rapid Acting Vaccine Against Nipah Virus
#8GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#9VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#10SELF-REPLICATING RNA MOLECULES AND APPLICATION THEREOF
#11Vaccine Compositions For Preventing Coronavirus Disease
#12ARMED CHIMERIC ONCOLYTIC VIRUSES
#13COMPOSITION AND METHODS FOR RECOMBINANT LENTIVIRAL PRODUCTION
#14CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY
#15AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION
#16COMBINATIONS OF VIRAL PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF
#17ONCOLYTIC VIRUS AND USE THEREOF
#18METHOD FOR INFECTING CELLS WITH VIRUS
#19VESICULAR STOMATITIS VIRUSES
#20CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES
#21METHODS AND MATERIALS FOR TREATING CANCER
#22Vesicular stomatitis virus and virus rescue system
#23COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER
#24ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS
#25BLOCKADE OF IFN SIGNALING DURING CANCER VACCINATION
#26COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES
#27Method for infecting cells with virus
#28TARGETING PD-L1 ON TUMOR CELLS
#29MUTANT VSV ECTODOMAIN POLYPEPTIDE AND USES THEREOF
#30ONCOLYTIC VIRUSES AND METHODS FOR USING ONCOLYTIC VIRUSES
#31METHOD FOR VIRUS PRODUCTION
#32METHODS AND MATERIALS FOR TREATING CANCER
#33Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins
#34GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#35USES AND METHODS FOR ONCOLYTIC VIRUS TARGETING OF IL-4/IL-13 AND FUSIONS THEREOF
#36VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#37Recombinant vectors encoding Zika virus protein subunits
#38VACCINE COMPOSITION
#39Recombinant viral vectors
#40RECOMBINANT VIRAL VECTOR AND USES THEREOF
#41Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen
#42Vesicular stomatitis viruses
#43Vesicular stomatitis virus and virus rescue system
#44Oncolytic viral delivery of therapeutic polypeptides
#45Zika virus vaccine
#46Vaccine composition
#47Vaccine composition
#48Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses
#49Transgenic VERO-CD4/CCR5 cell line
#50Oncolytic rhabdovirus expressing IL12
#51Optimized HIV envelope gene and expression thereof
#52Targeting PD-L1 on tumor cells
#53Methods and materials for treating cancer
#54Recombinant viral vectors
#55VSV/NDV hybrid viruses for oncolytic therapy of cancer
#56Oncolytic viral delivery of therapeutic polypeptides
#57Methods and materials for treating cancer
#58Vesicular stomatitis viruses
#59Cocal vesiculovirus envelope pseudotyped retroviral vectors
#60Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#61PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
#62Vaccination methods
#63Recombinant viral vectors
#64Transgenic Vero-CD4/CCR5 cell line
#65Optimized HIV envelope gene and expression thereof
#66LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#67Vesicular stomatitis virus and virus rescue system
#68Attenuated recombinant vesicular stomatitis viruses comprising modified matrix proteins
#69Replication-competent VSV-HIV Env vaccines
#70Methods and materials for treating cancer
#71Methods and materials for treating cancer
#72Recombinant isfahan viral vectors
#73Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
#74Vesicular stomatitis viruses
#75Methods to improve vector expression and genetic stability
#76Recombinant viral vectors
#77Modified matrix proteins of vesicular stomatitis virus
#78Vaccine composition
#79Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues
#80Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins
#81Norovirus immunogens and related materials and methods
#82Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#83Method of vaccination comprising a histone deacetylase inhibitor
#84Methods and assays for treating filoviridae infections
#85Methods to improve vector expression and genetic stability
#86Recombinant viral vectors
#87Vesicular stomatitis viruses
#88Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#89Methods and materials for treating cancer
#90Glucagon-like-peptide-2 (GLP-2) analogues
#91IMMUNOGENIC COMPOSITION AND METHODS
#92COCAL VESICULOVIRUS ENVELOPE PSEUDOTYPED RETROVIRAL VECTORS
#93Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
#94Vaccination methods
#95Expression system
#96LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#97COMPOSITIONS AND METHODS FOR TREATING EBOLA VIRUS INFECTION
#98Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues
#99Glucagon-like-peptide-2 (GLP-2) analogues
#100Pre-or post-exposure treatment for filovirus or arenavirus infection
#101MULTICOMPONENT VACCINE
#102RECOMBINANT VIRAL VECTORS
#103TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#104VIRUS MEDIATED CYTOPLASMIC EXPRESSION OF DNA VACCINES
#105Recombinant viruses comprising the membrane-proximal domain of VSV G protein
#106Recombinant VSV For The Treatment of Tumor Cells
#107HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
#108Expression system
#109Purification processes for isolating purified vesicular stomatitis virus from cell culture
#110Glucagon-like-peptide-2 (GLP-2) analogues
#111Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#112Immunogenic composition and methods
#113Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues
#114Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
#115Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA